Literature DB >> 30152738

Severity of Kratom (Mitragyna speciosa Korth.) Psychological Withdrawal Symptoms.

Darshan Singh1, Suresh Narayanan2, Christian P Müller3, Marc T Swogger4, Azlan Abdul Rahim1, Mohammad Farris Iman Leong Bin Abdullah5, Balasingam K Vicknasingam1.   

Abstract

Kratom leaves (Mitragyna speciosa Korth.) are traditionally used in Southeast Asia for their medicinal value. Self-report studies suggest that cessation from chronic kratom tea consumption (freshly brewed kratom tea) was associated with unpleasant psychological symptoms. This study sought to assess the severity of anxiety and depression during kratom cessation. Regular kratom users (N = 150) were recruited from the northern state of Penang (Malaysia) for this retrospective study. The Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) scales were used to assess the severity of the symptoms of anxiety and depression. Most respondents (70%) experienced symptoms of mild anxiety, while 81% experienced symptoms of mild depression during kratom cessation. Those who consumed higher quantities of kratom tea daily (≥4 glasses) had higher odds of reporting longer duration of kratom use history (OR = 4.8, 95% CI 2.3 -10.1, p < 0.001), higher frequency of daily kratom use (≥4 times) (OR = 72, CI 9.5- 543.1, p < 0.001), and were more likely to experience moderate symptoms of depression (OR = 2.9, CI 1.1-7.3, p = 0.020) during kratom cessation than those who consumed between one and three glasses of kratom tea per day. Cessation from regular and long-term kratom tea consumption was not associated with symptoms of high anxiety or depression.

Entities:  

Keywords:  Anxiety; BDI; Malaysia; kratom dependence; mitragynine; psychological symptoms

Mesh:

Substances:

Year:  2018        PMID: 30152738     DOI: 10.1080/02791072.2018.1511879

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  14 in total

1.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

2.  Mitragynine Attenuates Morphine Withdrawal Effects in Rats-A Comparison With Methadone and Buprenorphine.

Authors:  Rahimah Hassan; Cheah Pike See; Sasidharan Sreenivasan; Sharif M Mansor; Christian P Müller; Zurina Hassan
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

3.  Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2020-07-21

Review 4.  Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review.

Authors:  Steven C Eastlack; Elyse M Cornett; Alan D Kaye
Journal:  Pain Ther       Date:  2020-01-28

5.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16

6.  Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study.

Authors:  Antonio Metastasio; Elisabeth Prevete; Darshan Singh; Oliver Grundmann; Walter C Prozialeck; Charles Veltri; Giuseppe Bersani; Ornella Corazza
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

7.  Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada.

Authors:  Jeremy Y Ng; Muhammad Ans; Amn Marwaha
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-03-19

8.  Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2021-05-10

9.  Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Destiny Schriefer; Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

Review 10.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.